These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17945201)

  • 1. Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window.
    Ley JJ; Belayev L; Saul I; Becker DA; Ginsberg MD
    Brain Res; 2007 Nov; 1180():101-10. PubMed ID: 17945201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: neurobehavior, histopathology, and pharmacokinetics.
    Ley JJ; Vigdorchik A; Belayev L; Zhao W; Busto R; Khoutorova L; Becker DA; Ginsberg MD
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1090-100. PubMed ID: 15716383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia.
    Ginsberg MD; Becker DA; Busto R; Belayev A; Zhang Y; Khoutorova L; Ley JJ; Zhao W; Belayev L
    Ann Neurol; 2003 Sep; 54(3):330-42. PubMed ID: 12953265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats.
    Belayev L; Becker DA; Alonso OF; Liu Y; Busto R; Ley JJ; Ginsberg MD
    J Neurosurg; 2002 Jun; 96(6):1077-83. PubMed ID: 12066910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury.
    Ley JJ; Prado R; Wei JQ; Bishopric NH; Becker DA; Ginsberg MD
    Biochem Pharmacol; 2008 Jan; 75(2):448-56. PubMed ID: 17936251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
    Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats.
    Matucz E; Móricz K; Gigler G; Benedek A; Barkóczy J; Lévay G; Hársing LG; Szénási G
    Brain Res; 2006 Dec; 1123(1):60-7. PubMed ID: 17064671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
    Liu Y; Belayev L; Zhao W; Busto R; Belayev A; Ginsberg MD
    Eur J Pharmacol; 2001 Oct; 428(2):193-201. PubMed ID: 11675036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
    Belayev L; Khoutorova L; Atkins K; Gordon WC; Alvarez-Builla J; Bazan NG
    Exp Neurol; 2008 Dec; 214(2):253-8. PubMed ID: 18793637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid methyl esters and Solutol HS 15 confer neuroprotection after focal and global cerebral ischemia.
    Lin HW; Saul I; Gresia VL; Neumann JT; Dave KR; Perez-Pinzon MA
    Transl Stroke Res; 2014 Feb; 5(1):109-17. PubMed ID: 24323706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities.
    Yang L; Calingasan NY; Chen J; Ley JJ; Becker DA; Beal MF
    Exp Neurol; 2005 Jan; 191(1):86-93. PubMed ID: 15589515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
    Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
    Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Sharma SS; Kaundal RK
    Neurol Res; 2007 Apr; 29(3):304-9. PubMed ID: 17509231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
    Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
    Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
    Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
    Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia.
    Liu R; Wang X; Liu Q; Yang SH; Simpkins JW
    Neurosci Lett; 2007 Mar; 415(3):237-41. PubMed ID: 17331646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.